インドでの腫瘍科に最適なクリニックと費用をご発見ください2026

当クリニックのチームは、16ヶ月間で410件のロボット支援手術を実施し、99%以上の成功率を達成しました。 これには、悪性腫瘍および良性腫瘍に対するロボット支援手術、ならびに肥満外科手術が含まれます。患者は、成功率が高く痛みが少ないことから、ロボット支援手術を好みます。

インド医学研究評議会は、2021年に約139万件の新規がん症例が発生すると予測しており、悪性疾患はインドで最も一般的な疾患の一つとなっています。がん治療における主な問題は、高額な費用です。インドは、最新の治療法（外科的治療と非外科的治療）をほとんどの国よりも低コストで提供しています。同時に、治療の質と効果は他の国々と同等に高い水準を維持しています。

がんからの完全回復は議論の的となるテーマです。がんを患ったことがある人は、常に再発の可能性を秘めています。私たちは14年以上にわたり、インドのマハラシュトラ州ナーシクで9万人以上の悪性腫瘍患者を治療してきました。その多くは、観察期間を通して再発することなく過ごしました。再発を経験した患者もいましたが、私たちの治療のおかげで寛解に至りました。残念ながら、末期がんの患者の中には、病気を克服できずに亡くなる方も少数ながら存在します。私たちの第一の目標は、がんを治癒させ、できる限り長く命を延ばすことです。余命がどれくらいであっても、生活の質は最優先事項です。

A tumour board is a multidisciplinary team of specialists. It includes surgeons, oncologists, and pathologists who decide on a cancer treatment plan together. For oncology cases in India, this review is the standard approach. It ensures balanced care by removing individual bias and following international guidelines.

• Multidisciplinary team: Includes experts in medical, surgical, and radiation oncology, plus radiology and pathology.
• Clinical benefit: Boards catch staging errors and adjust the timing of chemotherapy, surgery, or radiation.
• Quality signal: Structured reviews at centres like Artemis Hospitals suggest higher coordinated decision-making standards.
• Efficiency: One review replaces multiple second opinions, saving time for complex or rare cases.

Bookimed Expert Insight: Patient volume directly affects tumour board efficacy. Clinics like Apollo Hospital Indraprastha and Manipal Hospitals serve over 1,000,000 patients annually. This case volume means their boards have reviewed almost every cancer subtype. This gives them a deeper database for comparison than smaller, local facilities.

Patient Consensus: Patients in India feel more confident when a panel reviews their actual imaging and pathology. They appreciate friendly staff and doctors who clearly explain these collaborative plans. Many suggest having a companion to help navigate hospital logistics.

Leading Indian oncologists provide remote second opinions through digital consultations. Patients can access specialist reviews for various cancers, including leukaemia and breast tumours. They do this by submitting pathology reports and radiology scans. These reviews often include a multidisciplinary tumour board assessment to confirm diagnosis and staging.

• Specialist expertise: Dr Sidharth Sahni serves as a breast surgical oncologist for multiple international embassies.
• Expert review: Dr Surender Dabas has performed over 8,000 head-neck and thoracic cancer surgeries.
• Bone marrow insights: Dr Dharma Choudhary leads the Bone Marrow Transplant Department at BLK Hospital.
• Radiation oncology: Dr S Hukku has over 40 publications in international scientific journals.

Bookimed Expert Insight: Clinics like Artemis or Manipal handle many international patients. These centres have streamlined systems for remote file review. They treat 1,000,000+ patients annually, which leads to faster processing of digital files. This setup allows specialists to return structured treatment recommendations within days without immediate travel.

Patient Consensus: Patients find that Indian specialists explain all treatment options clearly. They provide new drug suggestions and hope for recovery. While some mention hospital wait times, they praise the surgical expertise and the thorough digital test results.

Indian oncology centres provide precision therapies including immunotherapy and targeted therapy. Major facilities in Delhi and Bengaluru use next-generation sequencing to create personalised plans. These treatments target specific genetic mutations and proteins to treat breast, lung, and blood cancers effectively.

• Therapy range: Immunotherapy ranges from お問い合わせください to お問い合わせください for various stages.
• Specific drugs: Immunotherapy including Keytruda costs between お問い合わせください and お問い合わせください per cycle.
• Diagnostic tools: PET/CT scans for precise staging cost from $400 to $600.
• Personalised care: Specialists like Dr Sarat Chandra P at Manipal Hospitals focus on precision medicine.

Bookimed Expert Insight: India is becoming a hub for indigenous precision medicine breakthroughs. Global drug brands are available. However, homegrown innovations like NexCAR19 therapy offer cellular treatment at significantly lower costs than imported alternatives. This makes high-level biological therapy accessible to international patients who find Western prices prohibitive.

Patient Consensus: Patients in India find the clinical level of surgery and drug selection impressive. They recommend having support for logistics. They also note that medical expertise and English-speaking doctors provide high-quality care.

Indian oncology centres use the same primary chemotherapy medications as Australia. Both nations follow international standards like guidelines from NCCN and ESMO. While active chemical compounds are identical, India relies on domestically produced generics. This reduces medical costs while maintaining efficacy for standard cancer treatments.

• Drug overlap: Clinics use standard agents including Cisplatin, Paclitaxel, and 5-Fluorouracil.
• Generic manufacturing: Indian facilities primarily use high-quality local generics instead of originators.
• Regulatory speed: India often approves and stocks new immunotherapy drugs very rapidly.
• Accredited facilities: Leading centres like Apollo Hospital Indraprastha hold JCI accreditation.

Bookimed Expert Insight: Leading Indian specialists like Dr Sidharth Sahni at Apollo Hospital serve high-level Australian entities. This helps local treatment plans align with Western expectations. Our data shows JCI-accredited clinics in major cities manage 1,000,000+ international patients yearly. These high volumes mean hospital pharmacies stock fresh batches of chemotherapy drugs. This constant turnover helps maintain medicine potency at its peak.

Patient Consensus: Patients find that Indian oncologists prescribe innovative drugs and internationally recognised regimens. These plans closely match Australian protocols. The clinical care and surgical results are highly professional. However, navigating hospital organisation is easier with an accompanying person.

Oncology patients in India typically move from consultation to diagnosis within 32 days. Treatment starts quickly after, averaging 20 days. Private centres like Apollo Hospital Indraprastha often fast-track this process. They coordinate staging and surgery within 7 to 14 days for urgent cases.

• Diagnostic turnaround: Definitive tests including biopsy and PET-CT usually take about 32 days.
• Treatment initiation: Median time from confirmed diagnosis to starting therapy is 20 days.
• Clinical variation: Urgent haematological cases start in 11 days. Radiotherapy requires 27–30 days.
• Hospital systems: Integrated centres like Manipal Hospitals coordinate pathology and radiology to reduce delays.

Bookimed Expert Insight: Large Indian networks often re-validate pathology slides from smaller clinics for accuracy. Patients can save roughly 5 to 7 days by bringing original biopsy slides to their first appointment. This prevents the need for a new biopsy before starting treatment.

Patient Consensus: Patients note that major hospitals move very fast once you arrive. While repeat testing is common for safety, international visitors appreciate how specialists coordinate care in one location. India provides a good level of care at high-volume tertiary centres.

International patients access supportive and palliative care through India’s major private hospital networks and oncology hubs. Leading centres integrate pain management, nutritional counselling, and psychosocial support into treatment. Facilities like Apollo Hospital Indraprastha and Manipal Hospitals use specialised international desks to coordinate these services.

• Multidisciplinary approach: Major hospitals include symptom relief in active chemotherapy and radiotherapy protocols.
• Specialised pain management: Care teams use medications and localised therapies for chronic pain.
• Psychosocial resources: Counselling services help international patients and their families navigate intensive treatment.
• Nutritional support: Targeted dietary plans offset side effects from surgeries or systemic therapies.

Bookimed Expert Insight: India’s third-largest healthcare provider, Manipal Hospitals, manages roughly 2,000,000 patients annually. Data shows that larger systems like this or Apollo Hospital Indraprastha provide robust infrastructure. Patients should confirm that symptom management teams are available from the day of diagnosis.

Patient Consensus: Patients report that while medical treatment is high-quality, having a coordinator is essential. They note that hospital food is excellent and private bays provide comfort during recovery.

インドの医療制度は費用対効果の高いモデルに基づいている。ほとんどの病院は私立であり、医療サービスに対する自己負担額は年間GDPの65%を占めている。

インドでは140万人の医師が質の高い医療を提供しています。インドの医療の74%は民間です。地元の医療センターは、サービスの質と患者の安全性の高さを証明する国際的および国内的な認証を取得しています。

• JCI（国際医療機関評価機構）は、世界中の医療サービスの質と安全性を向上させるための国際機関です。
• NABH（National Accreditation Board for Hospitals and Healthcare Providers：病院および医療機関のための国家認定委員会）は、インド国内の医療機関の認定を行うインドの品質評議会です。

インドにはJCI認定を受けた医療センターが39施設あるのに対し、ドイツには20施設、イスラエルには10施設ある。

インドには、価格帯やサービスレベルが異なる様々なホテルがあります。ほとんどの観光客は4つ星または5つ星ホテルを選びます。これらのホテルは、快適な滞在に必要なすべてを提供しています。ヨーロッパ料理やアジア料理の豊富なメニュー、広々とした手入れの行き届いた敷地、子供から大人まで楽しめるエンターテイメントなどです。中にはウォーターパークを併設しているホテルもあります。予算重視の旅行者は、ハーフボード（朝食・夕食付き）または食事なしのリーズナブルな3つ星ホテルを予約することもできます。

外国人患者は電子ビザ（e-ビザ）を取得する必要があります。このビザでの滞在期間は最長6ヶ月です。インドでの医療を受けるためのビザ要件については、こちらをご覧ください。

インドへのビザ取得には、いくつかの書類が必要です。これらの書類には以下が含まれます。

• 身分証明書
• オンラインビザ申請書のコピー
• 収入証明書および資金の利用可能性
• サイズ2の最新写真
• 居住地住所の確認
• 航空券とホテルの予約
• インドでの治療に必要な医療証明書。